Results 141 to 150 of about 46,577 (260)
Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center
, 2021 Alesia Khan, Claire Woodley, Deepti Radia, G. Mikhaeel, J.L. Brady, Natalia Curto‐García, Patrick Harrington, Jennifer O’Sullivan, Shahram Kordasti, Yara Nakhleh Francis, Susan Asirvatham, Sahra Ali, Priya Sriskandarajah, Jamie Saunders, Hugues de Lavallade, Donal P. McLornan, Claire Harrison +16 moreopenalex +1 more sourceSecond primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients [PDF]
, 2019 Barbara Mora, Elisa Rumi, Paola Guglielmelli, Daniela Barraco, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason Gotlib, Jean‐Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Chiara Cavalloni, Daniela Pietra, Tiziano Barbui, Giada Rotunno, Mario Cazzola, Alessandro M. Vannucchi, Toni Giorgino, Francesco Passamonti +25 moreopenalex +1 more sourceWhich patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations [PDF]
, 2016 Barbui, T, Barosi, G, Birgegård, G, Cervantes, F, Griesshammer, M, Harrison, C., Hehlmann, R, Kiladjian, J-J, Kröger, N, Marchetti, M, McMullin, M F, Passamonti, F, Vannucchi, A +12 morecore +1 more sourceHigh Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis
, 2022 Nico Gagelmann, Rachel B. Salit, Thomas Schroeder, Anita Badbaran, Christina Rautenberg, Victoria Panagiota, Christine Wolschke, Felicitas Thol, Bruno Cassinat, Marie Robin, Michael Heuser, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kröger +13 moreopenalex +1 more sourceCD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms. [PDF]
Ann HematolDemoy M, Bauvais M, Vely A, Nicol T, Riou J, Le Jeanne H, Bauduin A, Rambaud H, Boyer F, Geneviève F, Boussaroque A, Copin MC, Ugo V, Orvain C, Luque Paz D. +14 moreeuropepmc +1 more source[Ruxolitinib combined with prednisone, thalidomide and danazol for treatment of myelofibrosis: a pilot study].
, 2019 Zefeng Xu, T J Qin, H L Zhang, L W Fang, Ling Pan, Nian Hu, S Q Qu, B Li, Zhijian Xiao +8 moreopenalex +2 more sources
